Related Experiment Video
Updated: Nov 6, 2025

Sleeve Gastrectomy in Mice using Surgical Clips
Published on: November 14, 2020
Pre-operative glycaemic control and long-term survival in diabetic patients after coronary artery bypass grafting
Salil Deo1, Varun Sundaram2,3, Muhammad Adil Sheikh4
1Surgical Services, Louis Stokes Cleveland VA Medical Center, VA Northeast Ohio Healthcare System, Cleveland, OH, USA.
Insights
Elevated pre-operative glycated haemoglobin (HbA1c) levels above 8% in patients undergoing coronary artery bypass grafting (CABG) are linked to higher mortality and adverse cardiac events. Managing HbA1c is crucial for long-term outcomes after CABG surgery.
Area of Science:
- Cardiology
- Diabetology
- Surgical Outcomes
Background:
- Diabetes mellitus is a significant comorbidity in patients undergoing coronary artery bypass grafting (CABG).
- Pre-operative glycemic control, measured by glycated haemoglobin (HbA1c), may impact long-term outcomes after CABG.
Purpose of the Study:
- To evaluate the association between pre-operative glycated haemoglobin (HbA1c) levels and long-term outcomes in veterans undergoing isolated coronary artery bypass grafting (CABG).
Main Methods:
- Analysis of Veteran Affairs data from 2006-2018 for patients with diabetes mellitus undergoing isolated CABG.
- Patients were stratified into four groups based on pre-operative HbA1c levels (<6.5%, 6.5-8%, 8-10%, >10%).
- Multivariable Cox proportional hazards models and competing risks models were used to assess mortality, myocardial infarction (MI), and repeat revascularization.
Main Results:
- A total of 16,190 patients were analyzed, with a median follow-up of 5.8 years.
- Mortality rates increased with HbA1c levels >8%, particularly above 9%.
- Pre-operative HbA1c levels of 8-10% and >10% were associated with increased risk of MI (HR 1.24, 1.39) and reintervention (HR 1.20, 1.24) compared to HbA1c <8%.
Conclusions:
- Pre-operative HbA1c levels exceeding 8% are associated with an increased risk of mortality and adverse cardiac events in patients undergoing CABG.
- Optimizing glycemic control before CABG surgery may improve long-term patient outcomes.
Objectives:
We analysed the Veteran Affairs data to evaluate the association of pre-operative glycated haemoglobin (HbA1c) and long-term outcome after isolated coronary artery bypass grafting (CABG).
Methods:
Veterans with diabetes mellitus and isolated CABG (2006-2018) were divided into 4 groups (I: HbA1c <6.5%, II: HbA1c 6.5-8, III 8-10% and IV: HbA1c >10%). The relationship of pre-operative HbA1c and long-term survival was evaluated with a multivariable Cox proportional hazards model and reported as hazard ratios (HR). The cumulative incidence of secondary end-points [myocardial infarction (MI) and repeat revascularization (percutaneous intervention)] for each group was modelled as competing events with cause-specific Cox proportional hazards models.
Results:
Overall, 16 190 patients (mean age 64.9 years, male 98%; insulin dependent 53%) with diabetes mellitus underwent isolated CABG. We observed 19.4%, 45.4%, 27% and 8.2% patients in groups I, II, III and IV, respectively. Patients with HbA1c >10% were the youngest (mean age 60.9 years) and had high rates of Insulin dependence (78%). In patients with HbA1c >10%, improvement in levels was observed in 76%. The median follow-up observed was 5.8 (3.2-8.8) years. Compared to the study mean HbA1c (7.3%), mortality rate increased with HbA1c levels >8%, and especially with pre-operative HbA1c levels >9%. Compared to patients with HbA1c <8%, HbA1c 8-10% and >10% were associated with increased MI (HR 1.24 and HR 1.39, respectively) and need for reintervention (HR 1.20 and HR 1.24, respectively).
Conclusions:
In patients undergoing CABG, pre-operative HbA1c >8% is associated with the increased risk of mortality and adverse cardiac events.
Related Concept Videos
Peripheral Artery Disease V: Postoperative Nursing Management
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Coronary Artery Disease V: Interprofessional Care
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational

